"10.1371_journal.pone.0049696","plos one","2012-11-29T00:00:00Z","Peter Hallersund; Lars Sjöström; Torsten Olbers; Hans Lönroth; Peter Jacobson; Ville Wallenius; Ingmar Näslund; Lena M Carlsson; Lars Fändriks","Department of Gastrosurgical Research and Education, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Molecular and Clinical Medicine and Center for Cardiovascular and Metabolic Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden","Conceived and designed the experiments: PH LF LS LMC. Performed the experiments: LS IN TO PJ HL VW. Analyzed the data: PH LF LMC LS VW. Wrote the paper: PH LF. Intellectual content: LMC LS IN TO PJ HL VW. Statistical analysis: PH. Obtained funding: LF LMC HL LS. Administrative, technical, or material support: IN TO PJ HL VW. Study supervision: LF LMC LS.","The authors would like to declare the following: Dr. Lars Sjöström, reports serving as a member of the board of Lenimen, receiving lecture fees from AstraZeneca and Johnson & Johnson, and providing an expert statement on drug effects and weight-loss effects on obesity for AstraZeneca; Dr Hans Lönroth reports receiving unrestricted research grants and travel grants from Johnson & Johnson; Dr. Lena Carlsson reports receiving consulting fees from AstraZeneca and owning stock in Sahltech; Dr Lars Fändriks reports receiving unrestricted reaserch grants from VSL#3 Pharmaceutical Inc. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2012","11","Peter Hallersund","PH",9,TRUE,4,6,5,2,TRUE,TRUE,FALSE,0,NA,FALSE
